JIANGSU YAHONG MEDITECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.18 CNY | -0.77% |
|
-4.78% | -51.95% |
| 06-25 | Yahong Meditech to Trial Drug Against Amoebae Infection | MT |
| 06-17 | ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals | CI |
Evolution of the average Target Price on Jiangsu Yahong Meditech Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
74da.gz9IDgaXYY8t4zYFB5KvBzeRLsG3phY02Yyz7Pqu8zc.rhJwb2reGNceoEYoVaL7bw_hHIn933RG7c7yqaPKkUDwCAVgVeA26xWRBg~847ca110ecdd8762db826b489479043b
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.18
CNY
Average target price
12.28
CNY
Spread / Average Target
+137.16%
High Price Target
16.57
CNY
Spread / Highest target
+219.88%
Low Price Target
8
CNY
Spread / Lowest Target
+54.44%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688176 Stock
- Consensus Jiangsu Yahong Meditech Co., Ltd.
